UNSPSC 51382305: Tolfenamic acid

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C14H12ClNO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3G943U18KM, chemically known as benzoic acid, 2-((3-chloro-2-methylphenyl)amino)- (9ci) but generally known as tolfenamic acid, which bears US NIH Compound Identifier 5507. European Medicines Agency schedules Tolfenamic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11155MIG.

UNSPSC 51382305 Tolfenamic acid is a Commodity code representing pharmaceutical products, though recent state and local procurement activity under this code shows minimal alignment with the nominal pharmaceutical category. The single recent opportunity in the dataset—Seminole County, Florida's IFB for naloxone and drug deactivation systems—represents overdose-reversal and harm-reduction supplies rather than tolfenamic acid (a nonsteroidal anti-inflammatory drug). State and local governments procuring under this code appear to be sourcing emergency medical supplies and public-health interventions through competitive bidding, with annual volumes in the hundreds to low thousands of units and delivery frequency structured around operational needs rather than standing inventory models.

Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to its Community Health Building in Sanford, Florida; the response deadline was July 26, 2023. The bid required electronic submission through the county's e-Procurement Portal, included all shipping and delivery costs in vendor proposals, and structured the contract as a fixed-fee award with an initial two-year term and one-year renewal option. Vendors faced standard compliance requirements including drug-free workplace certification, E-Verify authorization, and specified insurance coverage. The procurement indicated potential FEMA funding and did not name explicit set-aside designations. No other recent state or local opportunities appear in the dataset under this code, suggesting minimal current activity or inconsistent classification of pharmaceutical and medical-supply procurements across state and local buying offices.